Literature DB >> 19160273

Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis.

Usama Ahmed Ali1, Frederik Keus, Joost T Heikens, Willem A Bemelman, Stephane V Berdah, H G Gooszen, Cees Jhm van Laarhoven.   

Abstract

BACKGROUND: Restorative proctocolectomy with ileo pouch anal anastomosis (IPAA) is the main surgical treatment for patients with ulcerative colitis (UC) and familial adenomatous polyposis (FAP). With the advancements of minimal-invasive surgery this demanding operation is increasingly being performed laparoscopically. Therefore, the presumed benefits of the laparoscopic approach need to be systematically evaluated.
OBJECTIVES: To compare the beneficial and harmful effects of laparoscopic versus open IPAA for patients with UC and FAP. SEARCH STRATEGY: We searched The Cochrane IBD/FBD Group Specialized Trial Register (April 2007), The Cochrane Library (Issue 1, 2007), MEDLINE (1990 to April 2007), EMBASE (1990 to April 2007), ISI Web of Knowledge (1990 to April 2007) and the web casts of the American Society of Colon and Rectal Surgeons (ASCRS) (up to 2006) for all trials comparing open versus laparoscopic IPAA. SELECTION CRITERIA: All trials in patients with UC or FAP comparing any kind of laparoscopic IPAA versus open IPAA. No language limitations were applied. DATA COLLECTION AND ANALYSIS: Two authors independently performed selection of trials and data extraction. The methodological quality of all included trials was evaluated to assess bias risk. Analysis of RCTs and non-RCTs was performed separately. Analyses were based on the intention-to-treat principle. Authors were requested additional information in case of missing data. Sensitivity and subgroup analyses were performed if appropriate. MAIN
RESULTS: Eleven trials included 607 patients of whom 253 (41%) in the laparoscopic IPAA group. Only one of the included trials was a randomised controlled trial. There were no significant differences in mortality or complications between the two groups. Reoperation and readmission rates were not significantly different. Operative time was significantly longer in the laparoscopic group both in the RCT and meta-analysis of non-RCTs (weighted mean difference (WMD) 91 minutes; 95% Confidence Interval (CI) 53 to 130). There were no significant differences between the two groups regarding postoperative recovery parameters. Total incision length was significantly shorter in the laparoscopic group, while two trials evaluating cosmesis found significantly higher cosmesis scores in the laparoscopic group. Other long-term outcomes were poorly reported. AUTHORS'
CONCLUSIONS: The laparoscopic IPAA is a feasible and safe procedure. Short-term advantages of the laparoscopic approach seem to be limited and their clinical significance is arguable. Large high-quality trials focusing on differences regarding specific postoperative complications, cosmesis, quality of life and costs are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19160273     DOI: 10.1002/14651858.CD006267.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  46 in total

1.  Laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis and impact of anti-tumor necrosis factor on postoperative outcomes.

Authors:  Ernst Hanisch; Dimosthenis E Ziogas
Journal:  Surg Endosc       Date:  2011-06       Impact factor: 4.584

2.  Electrothermal bipolar vessel ligation improves operative time during laparoscopic total proctocolectomy: a large single-center experience.

Authors:  Richard Garfinkle; Marylise Boutros; Neha Hippalgaonkar; Geva Maimon; Giovanna da Silva; Fabio Potenti; Steven D Wexner
Journal:  Surg Endosc       Date:  2015-10-28       Impact factor: 4.584

Review 3.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

4.  Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study.

Authors:  Benjamin Coquet-Reinier; Stéphane V Berdah; Jean-Charles Grimaud; David Birnbaum; Pierre-Alain Cougard; Marc Barthet; Ariadne Desjeux; Vincent Moutardier; Christian Brunet
Journal:  Surg Endosc       Date:  2010-01-28       Impact factor: 4.584

5.  Single-site laparoscopic colorectal surgery provides similar lengths of hospital stay and similar costs compared with standard laparoscopy: results of a retrospective cohort study.

Authors:  David B Stewart; Arthur Berg; Evangelos Messaris
Journal:  J Gastrointest Surg       Date:  2014-01-10       Impact factor: 3.452

Review 6.  Laparoscopic surgery for ulcerative colitis: a review of the literature.

Authors:  Keisuke Hata; Shinsuke Kazama; Hiroaki Nozawa; Kazushige Kawai; Tomomichi Kiyomatsu; Junichiro Tanaka; Toshiaki Tanaka; Takeshi Nishikawa; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Surg Today       Date:  2014-10-28       Impact factor: 2.549

Review 7.  Overlooked Long-Term Complications of Colorectal Surgery.

Authors:  Matthew D Giglia; Sharon L Stein
Journal:  Clin Colon Rectal Surg       Date:  2019-04-02

8.  The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes.

Authors:  Daniel Herzig; Karin Hardiman; Martin Weiser; Nancy You; Ian Paquette; Daniel L Feingold; Scott R Steele
Journal:  Dis Colon Rectum       Date:  2017-09       Impact factor: 4.585

Review 9.  [The technique of restorative proctocolectomy with ileal J‑pouch : Standards and controversies].

Authors:  J Hardt; P Kienle
Journal:  Chirurg       Date:  2017-07       Impact factor: 0.955

Review 10.  Minimally invasive approaches for the treatment of inflammatory bowel disease.

Authors:  Marco Zoccali; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.